Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 31, 2017
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologicsJessica D Sims, Jan Michael Taguiam, Felix Alonso-Valenteen, et al.
Diagnostics (Basel, Switzerland)|July 15, 2026
The Sepsis ImmunoScore Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available BiomarkersGregory L Watson, Lincoln C Updike, Carlos G López-Espina, et al.
Physiological Genomics|March 12, 2025
From castaways to discoveries: unveiling treasures in skin RNAseq using a novel multidimensional data processing workflow including infection-host dynamicsDisha Bhargava, Alec Labadie, Rebecca L Hanson-Rios-Stutz, et al.
Genome Announcements|January 24, 2015
Complete Genome Sequence of Anaeromyxobacter sp. Fw109-5, an Anaerobic, Metal-Reducing Bacterium Isolated from a Contaminated Subsurface EnvironmentC Hwang, A Copeland, S Lucas, et al.
Microorganisms|September 28, 2024
SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential ProteinsJeremy W Prokop, Sheryl Alberta, Martin Witteveen-Lane, et al.
JAMA Network Open|February 13, 2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm TrialMatthew D Sims, Sahil Khanna, Paul Feuerstadt, et al.
Health Equity|April 26, 2024
"Hang Ups, Let Downs, Bad Breaks, Setbacks": Impact of Structural Socioeconomic Racism and Resilience on Cognitive Change Over Time for Persons Racialized as BlackParis B Adkins-Jackson, Boeun Kim, César Higgins Tejera, et al.
Nature Communications|August 22, 2025
Multivariate protein landscape of host response in hospitalised patients with suspected infection in the emergency departmentPratik Sinha, Alexandra B Spicer, Sivasubramanium Bhavani, et al.
The Lancet. Gastroenterology & Hepatology|May 22, 2026
The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trialMan-Fung Yuen, Edward Gane, Jacinta A Holmes, et al.
Epidemiology (Cambridge, Mass.)|March 31, 2025
Approaches to Timescale Choice in Cognitive Aging Research and Potential Implications for Estimated Exposure Effects: Coordinated Analyses in 10 Cohorts of Older AdultsEleanor Hayes-Larson, Ryan M Andrews, Katrina L Kezios, et al.
Pageof 19